BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2541718)

  • 1. Biological and chemical characterization of basic FGF-saporin mitotoxin.
    Lappi DA; Martineau D; Baird A
    Biochem Biophys Res Commun; 1989 Apr; 160(2):917-23. PubMed ID: 2541718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic FGF-SAP mitotoxin in the hippocampus. Specific lethal effect on cells expressing the basic FGF receptor.
    Gonzalez AM; Lappi DA; Buscaglia ML; Carman LS; Gage FH; Baird A
    Ann N Y Acad Sci; 1991; 638():442-4. PubMed ID: 1664696
    [No Abstract]   [Full Text] [Related]  

  • 3. The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor.
    Lappi DA; Maher PA; Martineau D; Baird A
    J Cell Physiol; 1991 Apr; 147(1):17-26. PubMed ID: 1645359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor complexed to the cytotoxin saporin is growth inhibitory but not cytotoxic for embryonal carcinoma cells.
    Miller K; Wilder PJ; Rizzino A
    Cytotechnology; 1993; 13(2):69-78. PubMed ID: 7764580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines.
    Tetzke TA; Caton MC; Maher PA; Parandoosh Z
    Clin Exp Metastasis; 1997 Nov; 15(6):620-9. PubMed ID: 9344046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective elimination of fibroblasts from pancreatic islet monolayers by basic fibroblast growth factor-saporin mitotoxin.
    Beattie GM; Lappi DA; Baird A; Hayek A
    Diabetes; 1990 Aug; 39(8):1002-5. PubMed ID: 2165003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a saporin mitotoxin specifically cytotoxic to cells bearing the granulocyte-macrophage colony-stimulating factor receptor.
    Lappi DA; Martineau D; Sarmientos P; Garofano L; Aranda AP; Miyajima A; Kitamura T; Baird A
    Growth Factors; 1993; 9(1):31-9. PubMed ID: 8347350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of a homogeneous chemical conjugate between basic fibroblast growth factor and saporin.
    Buechler YJ; Sosnowski BA; Victor KD; Parandoosh Z; Bussell SJ; Shen C; Ryder M; Houston LL
    Eur J Biochem; 1995 Dec; 234(3):706-13. PubMed ID: 8575426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic fibroblast growth factor in cells derived from Dupuytren's contracture: synthesis, presence, and implications for treatment of the disease.
    Lappi DA; Martineau D; Maher PA; Florkiewicz RZ; Buscaglia M; Gonzalez AM; Farris J; Hamer M; Fox R; Baird A
    J Hand Surg Am; 1992 Mar; 17(2):324-32. PubMed ID: 1314273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin.
    Ying W; Martineau D; Beitz J; Lappi DA; Baird A
    Cancer; 1994 Aug; 74(3):848-53. PubMed ID: 8039113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic fibroblast growth factor-saporin mitotoxin. In vitro studies of its cell-killing activity and of substances that alter that activity.
    Martineau D; Lappi DA; Amburn E; Baird A
    Ann N Y Acad Sci; 1991; 638():438-41. PubMed ID: 1785818
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo.
    Beitz JG; Davol P; Clark JW; Kato J; Medina M; Frackelton AR; Lappi DA; Baird A; Calabresi P
    Cancer Res; 1992 Jan; 52(1):227-30. PubMed ID: 1309225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of ribosome-inactivating protein saporin is not mediated through alpha2-macroglobulin receptor.
    Bagga S; Hosur MV; Batra JK
    FEBS Lett; 2003 Apr; 541(1-3):16-20. PubMed ID: 12706812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the heterogeneity of chemically conjugated targeted toxins: homogeneous basic FGF-saporin.
    Lappi DA; Matsunami R; Martineau D; Baird A
    Anal Biochem; 1993 Aug; 212(2):446-51. PubMed ID: 8214586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale purification and characterization of recombinant fibroblast growth factor-saporin mitotoxin.
    McDonald JR; Ong M; Shen C; Parandoosh Z; Sosnowski B; Bussell S; Houston LL
    Protein Expr Purif; 1996 Aug; 8(1):97-108. PubMed ID: 8812840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and activities of a recombinant basic fibroblast growth factor-saporin fusion protein.
    Lappi DA; Ying W; Barthelemy I; Martineau D; Prieto I; Benatti L; Soria M; Baird A
    J Biol Chem; 1994 Apr; 269(17):12552-8. PubMed ID: 8175664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations.
    Reiland J; Rapraeger AC
    J Cell Sci; 1993 Aug; 105 ( Pt 4)():1085-93. PubMed ID: 8227197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatotoxicity of immunotoxins made with saporin, a ribosome-inactivating protein from Saponaria officinalis.
    Stirpe F; Derenzini M; Barbieri L; Farabegoli F; Brown AN; Knowles PP; Thorpe PE
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(5):259-71. PubMed ID: 2889289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amino-terminal fragment of human urokinase directs a recombinant chimeric toxin to target cells: internalization is toxin mediated.
    Fabbrini MS; Carpani D; Bello-Rivero I; Soria MR
    FASEB J; 1997 Nov; 11(13):1169-76. PubMed ID: 9367352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor-2-toxin induced cytotoxicity: differential sensitivity of co-cultured vascular smooth muscle cells and endothelial cells.
    Lin PH; Ren D; Hirko MK; Kang SS; Pierce GF; Greisler HP
    Atherosclerosis; 1998 Apr; 137(2):277-89. PubMed ID: 9622271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.